NCT04955158 is a Phase 3 clinical trial of Dexmedetomidine in Sore Throat, sponsored by Assiut University.

Who is sponsoring NCT04955158?

NCT04955158 is sponsored by Assiut University.

What drugs are being tested in NCT04955158?

Interventions in NCT04955158: Dexmedetomidine, Ketamine, saline 0.9%.

What condition does NCT04955158 study?

NCT04955158 studies Sore Throat.

Is NCT04955158 still recruiting?

NCT04955158 is currently completed. Last updated 13 April 2023.

Last reviewed 2023-04-13 · How we verify

NCT04955158

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dexmedetpmidine Versus Ketamine for Postoperative Sore Throat in Sinus Surgery

Completed Phase 3 Last updated 13 April 2023

What this trial tests

Phase 3 trial testing Dexmedetomidine in Sore Throat in 143 participants. Completed in 15 February 2023.

Timeline

19 August 2021

Primary endpoint
1 February 2023

15 February 2023

Quick facts

Lead sponsor	Assiut University
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	143
Start date	19 August 2021
Primary completion	1 February 2023
Estimated completion	15 February 2023
Sites	1 location across Egypt

Drugs / interventions tested

Dexmedetomidine (dexmedetomidine) — full drug profile →
Ketamine (ketamine) — full drug profile →
saline 0.9% — full drug profile →

Conditions studied

Sore Throat — all drugs for Sore Throat →

Sponsor

Assiut University

Who can join

Adults 18 to 65, any sex, with Sore Throat. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this randomized clinical trial is to evaluate the impact of dexmedetomidine versus ketamine soaked pharyngeal packing on postoperative sore throat in functional endoscopic sinus surgery (FESS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
NCT07398066 — DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) · NA · not yet recruiting
NCT07377981 — An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp · Phase 4 · not yet recruiting
NCT07306702 — Dexmedetomidine-Enhanced PCIA After Lobectomy in Nicotine-Dependent Patients · Phase 4 · withdrawn
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting

Other recruiting trials for Sore Throat

Currently open trials in the same condition.

NCT07486544 — Soaked Pharyngeal Packing Agents in Septoplasty · Phase 3 · recruiting
NCT07287293 — Endotracheal Tube Suctioning Versus No Suctioning During Emergence From General Anesthesia · NA · recruiting
NCT07517926 — Chewing Gum and Cold Gargle on Post-Bronchoscopy Symptoms · NA · recruiting
NCT06967896 — Different Models of Tracheal Catheters Are Used for Female Thyroid Glands · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04955158 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 13 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04955158.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing